
{
  "Company Overview": {
    "Name": "Petro Carbon & Chemicals Ltd",
    "Sector": "Chemicals",
    "Industry": "Chemicals",
    "Business Description": "Incorporated in 2007, Petro Carbon and Chemicals Ltd is in the business of manufacturing and marketing of Calcined Petroleum Coke. PCCL, a subsidiary of the Atha group, operates on a B2B model, primarily supplying Calcined Petroleum Coke (CPC) to government aluminum manufacturers, graphite electrode producers, titanium dioxide manufacturers, and other metallurgical, chemical, and steel industries.",
    "Market Position": "Not explicitly stated in the provided HTML."
  },
  "Financial Metrics": {
    "Market Cap": "₹ 512 Cr.",
    "Current Price": "₹ 207",
    "High/Low": "₹ 383 / ₹ 194",
    "Stock P/E": "12.7",
    "Book Value": "₹ 68.7",
    "Dividend Yield": "0.00%",
    "ROCE": "50.6%",
    "ROE": "67.3%",
    "Face Value": "₹ 10.0",
    "Debt-to-Equity Ratio": "Not explicitly stated, but implied debt reduction mentioned in Pros."
  },
  "Performance Trends": {
    "Quarterly Results": {
      "Sales": {
        "Mar 2023": "305",
        "Sep 2023": "349",
        "Mar 2024": "190",
        "Sep 2024": "176"
      },
      "Expenses": {
        "Mar 2023": "289",
        "Sep 2023": "274",
        "Mar 2024": "139",
        "Sep 2024": "167"
      },
      "Operating Profit": {
        "Mar 2023": "16",
        "Sep 2023": "76",
        "Mar 2024": "50",
        "Sep 2024": "9"
      },
      "Net Profit": {
        "Mar 2023": "5",
        "Sep 2023": "50",
        "Mar 2024": "32",
        "Sep 2024": "8"
      },
      "EPS": {
        "Mar 2023": "1.90",
        "Sep 2023": "19.27",
        "Mar 2024": "13.10",
        "Sep 2024": "3.35"
      }
    },
    "Annual Results": {
      "Sales": {
        "Mar 2018": "226",
        "Mar 2019": "221",
        "Mar 2020": "182",
        "Mar 2021": "152",
        "Mar 2022": "277",
        "Mar 2023": "516",
        "Mar 2024": "539",
        "TTM": "366"
      },
      "Net Profit": {
        "Mar 2018": "-1",
        "Mar 2019": "6",
        "Mar 2020": "5",
        "Mar 2021": "0",
        "Mar 2022": "6",
        "Mar 2023": "7",
        "Mar 2024": "82",
        "TTM": "41"
      },
      "EPS": {
        "Mar 2018": "-0.33",
        "Mar 2019": "2.39",
        "Mar 2020": "1.97",
        "Mar 2021": "0.17",
        "Mar 2022": "2.20",
        "Mar 2023": "2.54",
        "Mar 2024": "33.38",
        "TTM": "16.45"
      }
    },
    "Balance Sheet Highlights": {
      "Equity Capital": {
        "Mar 2018": "26",
        "Mar 2019": "26",
        "Mar 2020": "26",
        "Mar 2021": "26",
        "Mar 2022": "26",
        "Mar 2023": "26",
        "Mar 2024": "25",
        "Sep 2024": "25"
      },
      "Total Liabilities": {
        "Mar 2018": "205",
        "Mar 2019": "244",
        "Mar 2020": "179",
        "Mar 2021": "160",
        "Mar 2022": "277",
        "Mar 2023": "263",
        "Mar 2024": "284",
        "Sep 2024": "335"
      },
      "Total Assets": {
        "Mar 2018": "205",
        "Mar 2019": "244",
        "Mar 2020": "179",
        "Mar 2021": "160",
        "Mar 2022": "277",
        "Mar 2023": "263",
        "Mar 2024": "284",
        "Sep 2024": "335"
      }
    },
    "Cash Flow Summaries": {
      "Cash from Operating Activity": {
        "Mar 2018": "-28",
        "Mar 2019": "30",
        "Mar 2020": "-3",
        "Mar 2021": "-61",
        "Mar 2022": "62",
        "Mar 2023": "99",
        "Mar 2024": null
      },
      "Net Cash Flow": {
        "Mar 2018": "30",
        "Mar 2019": "-12",
        "Mar 2020": "-9",
        "Mar 2021": "4",
        "Mar 2022": "27",
        "Mar 2023": "-35",
        "Mar 2024": null
      }
    }
  },
  "Ratios": {
    "Growth Ratios": {
      "Compounded Sales Growth (10 Years)": null,
      "Compounded Sales Growth (5 Years)": "19%",
      "Compounded Sales Growth (3 Years)": "52%",
      "Compounded Sales Growth (TTM)": "-44%",
      "Compounded Profit Growth (10 Years)": null,
      "Compounded Profit Growth (5 Years)": "68%",
      "Compounded Profit Growth (3 Years)": "500%",
      "Compounded Profit Growth (TTM)": "-27%"
    },
    "Liquidity Ratios": {
      "Debtor Days": {
        "Mar 2018": "39",
        "Mar 2019": "66",
        "Mar 2020": "33",
        "Mar 2021": "58",
        "Mar 2022": "38",
        "Mar 2023": "10",
        "Mar 2024": "42"
      },
      "Inventory Days": {
        "Mar 2018": "118",
        "Mar 2019": "204",
        "Mar 2020": "197",
        "Mar 2021": "155",
        "Mar 2022": "173",
        "Mar 2023": "73",
        "Mar 2024": "80"
      },
      "Days Payable": {
        "Mar 2018": "0",
        "Mar 2019": "118",
        "Mar 2020": "68",
        "Mar 2021": "9",
        "Mar 2022": "2",
        "Mar 2023": "3",
        "Mar 2024": "36"
      },
      "Cash Conversion Cycle": {
        "Mar 2018": "156",
        "Mar 2019": "152",
        "Mar 2020": "163",
        "Mar 2021": "204",
        "Mar 2022": "209",
        "Mar 2023": "80",
        "Mar 2024": "87"
      },
      "Working Capital Days": {
        "Mar 2018": "140",
        "Mar 2019": "146",
        "Mar 2020": "152",
        "Mar 2021": "192",
        "Mar 2022": "205",
        "Mar 2023": "84",
        "Mar 2024": "76"
      }
    },
    "Profitability Ratios": {
      "ROCE %": {
        "Mar 2018": "8%",
        "Mar 2019": "9%",
        "Mar 2020": "2%",
        "Mar 2021": "7%",
        "Mar 2022": "9%",
        "Mar 2023": "51%",
        "Mar 2024": null
      },
      "ROE": {
        "10 Years": null,
        "5 Years": "24%",
        "3 Years": "34%",
        "Last Year": "67%"
      },
      "OPM %": {
        "Mar 2023": "5%",
        "Sep 2023": "22%",
        "Mar 2024": "26%",
        "Sep 2024": "5%"
      }
    },
    "Valuation Ratios": {
      "P/E Ratio": "12.7",
      "Price to Book": null, 
      "Market Cap / Sales": null
    }
  },
  "Peer Comparison": {
    "Peers": [
      {"Name": "Pidilite Inds.", "CMP": "2976.80", "P/E": "77.17", "Mar Cap": "151413.76", "Div Yld": "0.54", "NP Qtr": "540.30", "Qtr Profit Var": "18.75", "Sales Qtr": "3234.91", "Qtr Sales Var": "5.16", "ROCE": "29.74"},
      {"Name": "SRF", "CMP": "2277.60", "P/E": "59.78", "Mar Cap": "67513.72", "Div Yld": "0.32", "NP Qtr": "201.42", "Qtr Profit Var": "-33.03", "Sales Qtr": "3424.30", "Qtr Sales Var": "7.77", "ROCE": "12.71"},
      {"Name": "Linde India", "CMP": "6359.80", "P/E": "123.99", "Mar Cap": "54236.37", "Div Yld": "0.06", "NP Qtr": "104.39", "Qtr Profit Var": "-2.17", "Sales Qtr": "634.42", "Qtr Sales Var": "-10.81", "ROCE": "17.36"},
      {"Name": "Gujarat Fluoroch", "CMP": "4329.05", "P/E": "115.96", "Mar Cap": "47554.61", "Div Yld": "0.07", "NP Qtr": "121.00", "Qtr Profit Var": "128.30", "Sales Qtr": "1188.00", "Qtr Sales Var": "25.45", "ROCE": "9.76"},
      {"Name": "Godrej Industrie", "CMP": "1119.90", "P/E": "54.56", "Mar Cap": "37712.87", "Div Yld": "0.00", "NP Qtr": "488.86", "Qtr Profit Var": "229.46", "Sales Qtr": "4804.96", "Qtr Sales Var": "22.03", "ROCE": "5.59"},
      {"Name": "Deepak Nitrite", "CMP": "2596.85", "P/E": "44.57", "Mar Cap": "35419.23", "Div Yld": "0.29", "NP Qtr": "194.20", "Qtr Profit Var": "-5.31", "Sales Qtr": "2032.00", "Qtr Sales Var": "14.28", "ROCE": "21.65"},
      {"Name": "Himadri Special", "CMP": "546.85", "P/E": "56.02", "Mar Cap": "26996.96", "Div Yld": "0.09", "NP Qtr": "135.70", "Qtr Profit Var": "34.53", "Sales Qtr": "1136.92", "Qtr Sales Var": "13.18", "ROCE": "18.81"}
    ],
    "Median": {
      "CMP": "456.5",
      "P/E": "34.96",
      "Mar Cap": "1547.37",
      "Div Yld": "0.29",
      "NP Qtr": "9.66",
      "Qtr Profit Var": "6.63",
      "Sales Qtr": "168.44",
      "Qtr Sales Var": "6.18",
      "ROCE": "14.5"
    }
  },
  "Other Insights": {
    "Pros": [
      "Company has reduced debt.",
      "Company has delivered good profit growth of 67.7% CAGR over last 5 years",
      "Company has a good return on equity (ROE) track record: 3 Years ROE 34.2%",
      "Company's working capital requirements have reduced from 122 days to 76.0 days"
    ],
    "Cons": [
      "Though the company is reporting repeated profits, it is not paying out dividend",
      "Company might be capitalizing the interest cost",
      "Debtor days have increased from 29.9 to 41.9 days."
    ],
    "Disclaimer": "The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis."
  },
  "Documents": [
    {
      "Title": "Clarification - Financial Results",
      "Date": "11 December 2024"
    },
    {
      "Title": "Incorporation-XBRL",
      "Date": "14 November 2024"
    },
    {
      "Title": "General Updates",
      "Date": "14 November 2024"
    },
    {
      "Title": "Financial Result Updates",
      "Date": "13 November 2024"
    },
    {
      "Title": "Board Meeting Intimation",
      "Date": "7 November 2024"
    }
  ]
}
